C E Dunford1, R Hanano. 1. School of Nursing and Midwifery, Southampton University, UK. c.e.dunford@soton.ac.uk
Abstract
OBJECTIVES: This four-centre feasibility study was undertaken to determine whether Medihoney, a proprietary blend of honeys, is an acceptable treatment for patients with leg ulcers in terms of pain relief, odour control and overall patient satisfaction. METHOD: Forty patients whose leg ulcers had not responded to 12 weeks of compression therapy were recruited. Medihoney dressings were applied on their ulcers for the 12-week study period. All other aspects of their care, including the use of compression bandaging, remained unchanged. Their leg ulcers were assessed every two weeks. This included the use of a patient questionnaire. RESULTS: Overall, ulcer pain and size decreased significantly and odorous wounds were deodorised promptly. This had a positive impact on patient satisfaction with the Medihoney treatment. CONCLUSION: The results support the previously reported positive effects of honey and revealed a high patient acceptance for this treatment. Following these results, comparative clinical trials, which should also consider pain, are now recommended.
OBJECTIVES: This four-centre feasibility study was undertaken to determine whether Medihoney, a proprietary blend of honeys, is an acceptable treatment for patients with leg ulcers in terms of pain relief, odour control and overall patient satisfaction. METHOD: Forty patients whose leg ulcers had not responded to 12 weeks of compression therapy were recruited. Medihoney dressings were applied on their ulcers for the 12-week study period. All other aspects of their care, including the use of compression bandaging, remained unchanged. Their leg ulcers were assessed every two weeks. This included the use of a patient questionnaire. RESULTS: Overall, ulcer pain and size decreased significantly and odorous wounds were deodorised promptly. This had a positive impact on patient satisfaction with the Medihoney treatment. CONCLUSION: The results support the previously reported positive effects of honey and revealed a high patient acceptance for this treatment. Following these results, comparative clinical trials, which should also consider pain, are now recommended.
Authors: Bahram Biglari; Arash Moghaddam; Kai Santos; Gisela Blaser; Axel Büchler; Gisela Jansen; Alfred Längler; Norbert Graf; Ursula Weiler; Verena Licht; Anke Strölin; Brigitta Keck; Volker Lauf; Udo Bode; Tyler Swing; Ralph Hanano; Nicolas T Schwarz; Arne Simon Journal: Int Wound J Date: 2012-04-11 Impact factor: 3.315
Authors: Mariano del Sol Calderon; Carolina Schencke Figueroa; Jessica Salvo Arias; Alejandra Hidalgo Sandoval; Felipe Ocharan Torre Journal: Rev Lat Am Enfermagem Date: 2015 Feb-Apr
Authors: Katherine R Hixon; Robert C Klein; Christopher T Eberlin; Houston R Linder; William J Ona; Hugo Gonzalez; Scott A Sell Journal: Adv Wound Care (New Rochelle) Date: 2019-07-25 Impact factor: 4.730
Authors: Arne Simon; Kai Sofka; Gertrud Wiszniewsky; Gisela Blaser; Udo Bode; Gudrun Fleischhack Journal: Support Care Cancer Date: 2005-08-02 Impact factor: 3.603
Authors: Arne Simon; Kirsten Traynor; Kai Santos; Gisela Blaser; Udo Bode; Peter Molan Journal: Evid Based Complement Alternat Med Date: 2008-01-07 Impact factor: 2.629